D
Diethelm Messinger
Publications - 2
Citations - 2322
Diethelm Messinger is an academic researcher. The author has contributed to research in topics: Clinical endpoint & Cellular cardiomyoplasty. The author has an hindex of 2, co-authored 2 publications receiving 2274 citations.
Papers
More filters
Journal ArticleDOI
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial
Kai C. Wollert,Gerd Peter Meyer,Joachim Lotz,Stefanie Ringes Lichtenberg,Peter Lippolt,Christiane Breidenbach,Stephanie Fichtner,Thomas Korte,Burkhard Hornig,Diethelm Messinger,Lubomir Arseniev,Bernd Hertenstein,Arnold Ganser,Helmut Drexler +13 more
TL;DR: Intracoronary transfer of autologous bone-marrow-cells promotes improvement of left-ventricular systolic function in patients after acute myocardial infarction.
Journal ArticleDOI
Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
Kai C. Wollert,Gerd Peter Meyer,Jochen Müller-Ehmsen,Carsten Tschöpe,Vernon V.S. Bonarjee,Alf Inge Larsen,Andreas E. May,Klaus Empen,Emmanuel Chorianopoulos,Ulrich Tebbe,Johannes Waltenberger,Heiko Mahrholdt,Benedikta Ritter,Jens Pirr,Dieter Fischer,Mortimer Korf-Klingebiel,Lubomir Arseniev,Hans-Gert Heuft,Jan E. Brinchmann,Diethelm Messinger,Bernd Hertenstein,Arnold Ganser,Hugo A. Katus,Stephan B. Felix,Meinrad Gawaz,Kenneth Dickstein,Heinz-Peter Schultheiss,Dennis Ladage,Simon Greulich,Johann Bauersachs +29 more
TL;DR: The BOOST-2 trial does not support the use of nucleated BMCs in patients with STEMI and moderately reduced LVEF treated according to current standards of early PCI and drug therapy.